Key points are not available for this paper at this time.
Introduction Acetaldehyde dehydrogenase 2 (ALDH2) had reported as a prominent role in the development of cardiometabolic diseases among Asians. Our study aims to investigate the relationship between ALDH2 polymorphism and cardiometabolic risk factors in East Asian population. Method We searched databases of PubMed, Web of Science, and Embase updated to Oct 30 th , 2023. We extracted data of BMI, Hypertension, SBP, DBP, T2DM, FBG, PPG, HbA1c, TG, TC, LDL-C and HDL-C. Result In total, 46 studies were finally included in our meta-analysis, containing, 54068 GG and, 36820 GA/AA participants. All outcomes related to blood pressure revealed significant results (hypertension OR=0.83 0.80, 0.86; SBP MD=-1.48 -1.82, -1.14; DBP MD=-1.09 -1.58, -0.61). FBG showed a significant difference (MD=-0.10 -0.13, -0.07), and the lipid resulted significantly in some outcomes (TG MD=-0.07 -0.09, -0.04; LDL-C MD=-0.04 -0.05, -0.02). As for subgroups analysis, we found that in populations without severe cardiac-cerebral vascular diseases (CCVDs), GG demonstrated a significantly higher incidence of T2DM (T2DM OR=0.88 0.79, 0.97), while the trend was totally opposite in population with severe CCVDs (T2DM OR=1.29 1.00, 1.66) with significant subgroup differences. Conclusion Our updated meta-analysis demonstrated that ALDH2 rs671 GG populations had significantly higher levels of BMI, blood pressure, FBG, TG, LDL-C and higher risk of hypertension than GA/AA populations. Besides, to the best of our knowledge, we first report GG had a higher risk of T2DM in population without severe CCVDs, and GA/AA had a higher risk of T2DM in population with severe CCVDs. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO , identifier CRD42023389242.
Liu et al. (Tue,) studied this question.